These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16287787)

  • 1. Summaries for patients. Neuropsychological side effects of efavirenz.
    Ann Intern Med; 2005 Nov; 143(10):I43. PubMed ID: 16287787
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals.
    Clifford DB; Evans S; Yang Y; Acosta EP; Goodkin K; Tashima K; Simpson D; Dorfman D; Ribaudo H; Gulick RM
    Ann Intern Med; 2005 Nov; 143(10):714-21. PubMed ID: 16287792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply to Gonzalez and Everall: Lest we forget: neuropsychiatry and the new generation anti-HIV drugs.
    Colebunders R; Verdonck K
    AIDS; 1999 May; 13(7):869. PubMed ID: 10357394
    [No Abstract]   [Full Text] [Related]  

  • 4. Efavirenz and retinal toxicity.
    Lewis A; Mitchell S
    Eye (Lond); 2002 Jan; 16(1):107. PubMed ID: 11913879
    [No Abstract]   [Full Text] [Related]  

  • 5. Efavirenz-induced catatonia.
    Sabato S; Wesselingh S; Fuller A; Ray J; Mijch A
    AIDS; 2002 Sep; 16(13):1841-2. PubMed ID: 12218403
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of sudden psychiatric disorders related to efavirenz.
    Peyriere H; Mauboussin JM; Rouanet I; Fabre J; Reynes J; Hillaire-Buys D
    AIDS; 2001 Jul; 15(10):1323-4. PubMed ID: 11426084
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropsychiatric effects of efavirenz: delayed onset.
    Dawson S; Woods C
    Int J STD AIDS; 2005 Nov; 16(11):769-70. PubMed ID: 16303077
    [No Abstract]   [Full Text] [Related]  

  • 8. Efavirenz-induced psychosis.
    de la Garza CL; Paoletti-Duarte S; García-Martín C; Gutiérrez-Casares JR
    AIDS; 2001 Sep; 15(14):1911-2. PubMed ID: 11579266
    [No Abstract]   [Full Text] [Related]  

  • 9. No increase in CNS defects.
    AIDS Patient Care STDS; 2006 Oct; 20(10):732. PubMed ID: 17080576
    [No Abstract]   [Full Text] [Related]  

  • 10. Efavirenz-induced photoallergic dermatitis in HIV.
    Treudler R; Husak R; Raisova M; Orfanos CE; Tebbe B
    AIDS; 2001 May; 15(8):1085-6. PubMed ID: 11400003
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitivity syndrome associated with efavirenz therapy.
    Bossi P; Colin D; Bricaire F; Caumes E
    Clin Infect Dis; 2000 Jan; 30(1):227-8. PubMed ID: 10619772
    [No Abstract]   [Full Text] [Related]  

  • 12. Efavirenz-associated breast hypertrophy in HIV-infection patients.
    Mercié P; Viallard JF; Thiébaut R; Faure I; Rispal P; Leng B; Pellegrin JL
    AIDS; 2001 Jan; 15(1):126-9. PubMed ID: 11192857
    [No Abstract]   [Full Text] [Related]  

  • 13. Higher efavirenz plasma levels correlate with development of insomnia.
    Núñez M; González de Requena D; Gallego L; Jiménez-Nácher I; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2001 Dec; 28(4):399-400. PubMed ID: 11707679
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-related neutropaenia exacerbated by efavirenz.
    Healy BJ; Freedman AR
    HIV Med; 2006 Mar; 7(2):129-31. PubMed ID: 16420258
    [No Abstract]   [Full Text] [Related]  

  • 15. Manic syndrome associated with efavirenz overdose.
    Blanch J; Corbella B; García F; Parellada E; Gatell JM
    Clin Infect Dis; 2001 Jul; 33(2):270-1. PubMed ID: 11418896
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of amitriptyline to offset sleep disturbances caused by efavirenz.
    Koppel BS; Bharel C
    AIDS Patient Care STDS; 2005 Jul; 19(7):419-20. PubMed ID: 16053397
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropsychiatric reaction induced by abacavir.
    Colebunders R; Hilbrands R; De Roo A; Pelgrom J
    Am J Med; 2002 Nov; 113(7):616. PubMed ID: 12459415
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
    Soriano V; Dona C; Barreiro P; González-Lahoz J
    AIDS; 2000 Jul; 14(11):1672-3. PubMed ID: 10983663
    [No Abstract]   [Full Text] [Related]  

  • 19. Recreational substance use and tolerance of efavirenz in HIV-1 infected patients.
    Faggian F; Lattuada E; Lanzafame M; Antolini D; Concia E; Vento S
    AIDS Care; 2005 Oct; 17(7):908-10. PubMed ID: 16120507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe substitution for efavirenz.
    AIDS Patient Care STDS; 2004 Jan; 18(1):58. PubMed ID: 15080097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.